Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03650153Not ApplicableCompleted

Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal

Role: lead

NCT01705444Not ApplicableCompleted

The Spanner Prostatic Stent and Patient's Quality of Life

Role: lead

NCT02037906Not ApplicableCompleted

Escalating, Constant and Reduction Energy Output in SWL for Renal Stones

Role: lead

NCT02101931Phase 3Completed

A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

Role: lead

All 4 trials loaded